openPR Logo
Press release

GASTRIC CANCER TESTING MARKET TO WITNESS WIDESPREAD EXPANSION BY 2026

01-10-2020 11:22 AM CET | Health & Medicine

Press release from: Transparency Market Research

GASTRIC CANCER TESTING MARKET TO WITNESS WIDESPREAD EXPANSION

Cancer is caused due to abnormal cell growth in an uncontrolled manner, with the potential to spread or invade other parts of the body. Initiation of cancer takes place when changes in the gene make a single cell or a few cells to grow and multiply. This could result in the growth of the abnormal mass of tissue known as a tumor.

Gastric cancer, also known as stomach cancer, is the formation of cancer cells in the lining of the stomach. Risk factors for gastric cancer include diet and stomach disease. Symptoms of gastric cancer are indigestion and stomach pain or discomfort. The National Cancer Institute (NCI) of the U.S. estimated that there would be 28,000 new cases of stomach cancer in 2017. It also estimated that gastric cancer accounts for 1.7% of the new cancer cases in the U.S.

Report Overview @ https://www.transparencymarketresearch.com/gastric-cancer-testing-market.html

Increase in incidence of gastrointestinal tumors, lymphoma, and adenocarcinoma, a rise in alcohol consumption, surge in smoking, an increase in the geriatric population is anticipated to boost the growth of the global gastric cancer testing market from 2018 to 2026. However, stringent government regulations and the high cost of testing are projected to hamper the growth of the gastric cancer testing market.

In terms of test type, the global gastric cancer testing market can be segmented into computed tomography (CT or CAT) scan, chest X-ray, imaging tests, Helicobacter pylori test, laparoscopy, positron emission tomography (PET) scan, magnetic resonance imaging (MRI) scan, and upper gastrointestinal (GI) series. Based on gastric cancer type, the gastric cancer testing market can be divided into lymphoma, adenocarcinoma, carcinoid tumor, and gastrointestinal stromal tumor (GIST). In terms of end-user, the global gastric cancer testing market can be classified into hospitals, diagnostic centers, and others.

To Know the Scope of Our Report Get a Brochure on "Gastric Cancer Testing Market" here @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=61425

In terms of region, the global gastric cancer testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific is anticipated to lead the global gastric cancer testing market due to increase in the geriatric population and high consumption of salty, smoked, and pickled foods. According to the World Cancer Research Fund International, South Korea had the highest rate of gastric or stomach cancer in 2018, followed by Mongolia, Japan, and China.

According to the American Cancer Society, in the U.S., the number of new cases of stomach cancer has declined by approximately 1.5% every year in the last 10 years. In other parts of the world, particularly in less developed countries, stomach cancer is much more common. The gastric cancer testing market in North America and Europe is anticipated to witness comparatively sluggish growth.

According to the National Cancer Institute and the University of Texas MD Anderson Cancer Center, worldwide, approximately 26,200 new cases of stomach cancer are likely to be diagnosed in 2018. Over 60% of these include people aged 65 or over, and 68 years is considered to be the median age of diagnosis. Stomach cancer is considered to be the second leading cause of cancer death in much of the rest of the world, specifically Japan, South America, Eastern Europe, and parts of the Middle East. Factors responsible could be differences in diet, the rate of infection with bacteria known as Helicobacter pylori, and the environment.

Pre Book "Gastric Cancer Testing Market" Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=61425<ype=S

Key players in the global gastric cancer testing market include Agilent Technologies, Inc., Illumina, Inc., Thermo Fisher Scientific, Inc., General Electric Company, BD, Abbott, QIAGEN, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., and Koninklijke Philips N.V. These players have adopted growth strategies such as agreements, collaborations, partnerships, and new product development to gain a competitive advantage in the global market.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release GASTRIC CANCER TESTING MARKET TO WITNESS WIDESPREAD EXPANSION BY 2026 here

News-ID: 1893736 • Views:

More Releases from Transparency Market Research

Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion by 2036, Driven by Rising Opioid Use and Targeted Therapies
Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion …
The global opioid induced constipation (OIC) treatment market is witnessing steady and sustained growth as healthcare systems worldwide place increasing emphasis on comprehensive pain management and supportive care. Valued at US$ 2.9 billion in 2025, the market is projected to reach US$ 5.2 billion by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. Growth is primarily fueled by the rising prevalence of chronic
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product Type / By Impact Frequency | China • India • Japan • U.S.
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product T …
The global Pneumatic Flux Chipper Market is set to witness sustained and resilient growth over the next decade, underpinned by expanding heavy manufacturing activities, rising welding and fabrication demand, and continuous investments in industrial infrastructure across emerging and developed economies. According to the latest industry analysis, the market was valued at US$ 760.5 Mn in 2025 and is projected to reach US$ 1,680.8 Mn by 2036, expanding at a compound
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Billion in 2025 to US$ 244.4 Billion at 27% CAGR
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Bil …
The AI in automotive market is entering a phase of exponential expansion, supported by rapid digitization of vehicles, growing safety mandates, and consumer demand for intelligent mobility. The global market was valued at US$ 19.8 Bn in 2025 and is projected to reach US$ 244.4 Bn by 2036, registering a remarkable CAGR of 27% from 2026 to 2036. This growth trajectory reflects the transition of automobiles from mechanically driven products to
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable Drug Demand
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable …
The global hypodermic needles market was valued at approximately US$ 4.2 billion in 2025 and is projected to reach around US$ 7.9 billion by 2036, expanding at a CAGR of nearly 5.8% from 2026 to 2036, driven by the rising prevalence of diabetes, cancer, and chronic diseases, growing demand for injectable drugs and biologics, and the expansion of global vaccination and immunization programs; increasing adoption of safety-engineered and disposable needles,

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For